Affinity Biomarker Labs was established in 2017 at Imperial College London White City Campus by a team of clinical biochemists and analytical scientists, with over 40yrs combined experience working in NHS biochemistry labs, the diagnostic and pharmaceutical industries.
Our mission is to conduct high quality biomarker analysis, and thereby help translate discoveries from academic and biopharma research labs and support clinical trials by bringing analytical rigour and clinical expertise to the qualification, validation and testing of a diverse range of biomarkers.
Affinity expanded to new laboratories located nearby in January 2021.
Prior to joining Affinity, Laboratory Director Tracy Neal founded and managed the R&D laboratory within King’s College Hospital Department of Biochemistry. Over 27yrs Tracy and her team has built up an extensive track record including a broad range of biomarker study related publications in diverse areas including nutrition, oncology, CNS, cardiovascular, chronic kidney disease, pregnancy and pre-eclampsia.
Supported by a team of dedicated scientists, Affinity Biomarker Labs helps scientific groups deliver complex and challenging biomarker projects on an outsourced basis, freeing up significant time and resources within academic institutions and biopharma organisations to focus on other project and commercial priorities.